Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5844211 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2016 | 11 Pages |
Abstract
Despite the small sample sizes, this study documented a statistically significant effect of venlafaxine. Moreover, we showed that lower doses of zuclopenthixol and clonazepam were needed in the venlafaxine group, although this difference was not statistically significant. This was confirmed by multivariate analyses, where this difference reached statistical significance when using a combination of variables involving zuclopenthixol. Larger-scale studies are recommended to better investigate the effectiveness of venlafaxine treatment in patients with intellectual disabilities and ASD.
Keywords
SIBLOCFInternational Classification of Diseases 10th revisionCGI-SCGI-IABCCGIADI-RICD-10O-desmethylvenlafaxineODVKMOBehavioral disorderAutism spectrum disorderClinical Global ImpressionsAggressivenessSelf-injurious behaviorsAberrant Behavior Checklistlast observation carried forwardAutism Diagnostic Interview-Revisedselective serotonin reuptake inhibitorsSSRIASDVenlafaxine
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Giuliana Galli Carminati, Fabienne Gerber, Barbara Darbellay, Markus Mathaus Kosel, Nicolas Deriaz, Jocelyne Chabert, Marc Fathi, Gilles Bertschy, François Ferrero, Federico Carminati,